newsfilter
← Latest News
Business Wire·

Novocure Announces Optune Lua® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer

Novocure to launch Optune Lua in Japan with national reimbursement coverage Novocure (NASDAQ:NVCR) announced today that Japan's Ministry of Health, Labour and Welfare approved reimbursement for Optune Lua®